Dr. Raynard Kington Named as Interim Director of NIH

Posted by Joe Arite on November 3rd, 2008
Tags: NIH

Dr. Raynard Kington

Dr. Raynard Kington

After more than six years as director of the National Institutes of Health (NIH), Dr. Elias Zerhouni stepped down on Friday, October 31st. Dr. Zerhouni presided over the nation’s primary public funding source for biomedical research. Zerhouni tapped Dr. Raynard Kington to temporarily step into this role.

Kington has been serving as Deputy Director of the NIH since 2003. Prior to this, he served as NIH Associate Director for Behavioral and Social Sciences Research and Director of the NIH Office of Behavioral and Social Sciences Research since 2000. He also served as the Acting Director for the National Institute on Alcohol Abuse and Alcoholism (NIAAA) from January 2002 until September 2002.

Dr. Kington came to NIH from the Centers for Disease Control and Prevention (CDC). As Director of the Division of Health Examination Statistics in the CDC’s National Center for Health Statistics (NCHS), he led the National Health and Nutrition Examination Survey (NHANES), a comprehensive, ongoing survey of the health status, health behaviors, and diet of people in the United States.

Leave a Comment Comments RSS

Your comments are welcome. However, specific medical advice will not be provided, and we urge you to consult with a qualified physician for diagnosis and for answers to your personal questions.

C3 is not responsible for the medical accuracy of any comments left by persons other than C3 staff members. C3 staff members monitor comments and may respond where appropriate.

For the best response to your colorectal cancer treatment questions, please call our Answer Line at 1-877-4CRC-111 (1-877-427-2111).

Search C3

Donate

Support C3 and the Lisa Fund for Research

Donate to C3

Donate to The Lisa Fund

Learn more about the Lisa Fund

Sign Our Petition

Guarantee access to colorectal cancer screening for all Americans who need it.

Get Involved

Subscribe to the C3 website

Get C3 news & updates

Get the latest articles in your email inbox or news reader as soon as they are published.

Subscribe